Molecular changes that switch genes on or off can set the stage for breast cancer many years before the disease is diagnosed, research suggests.
The discovery could lead to a blood test that will help doctors identify women who are most at risk.
Scientists analysed blood samples from 1,380 women of various ages, 640 of whom went on to develop breast cancer.
A strong association was found between molecular modification of a white blood cell gene called ATM and breast cancer risk.
The scientists looked for evidence of a chemical effect called methylation, which acts as a "gene switch".
Women showing the highest methylation levels affecting the ATM gene were twice as likely to develop breast cancer as those with the lowest levels.
On average, the blood tests were carried out three years before diagnosis. In some cases they pre-dated the discovery of breast cancer by up to 11 years.
The results were especially clear in blood samples from women under the age of 60.
Methylation is an "epigenetic" mechanism that allows genes to be affected by exposure to environmental factors such as hormones, radiation, alcohol, smoking or pollution.
Increasingly, epigenetic effects are being seen as important drivers of cancer.
Dr James Flanagan, of Imperial College London, who led the new research, said: "We know that genetic variation
contributes to a person's risk of disease.
"With this new study we can now also say that epigenetic variation, or differences in how genes are modified, also has a role.
"We hope that this research is just the beginning of our understanding about the epigenetic component of breast cancer risk and in the coming years we hope to find many more examples of genes that contribute to a person's risk.
"The challenge will be how to incorporate all of this new information into the computer models that are currently used for individual risk prediction."
The findings are published in the journal Cancer Research.
Why breast cancer risk should be linked to changes in a white blood cell gene remains an unanswered question.
The ATM gene has also been associated with a number of other cancers, including lymphoma and leukaemia.
Dr Flanagan, a Breast Cancer Campaign scientific fellow, added: "So far we have found alterations in one small region of a gene that appear to associate with risk of disease, and so the next step with this epigenetic research is a genome-wide approach to try and find all the associated genes."
He said the research raised the possibility of a simple blood test to assess breast cancer risk at a very early stage.
Combined with other information, such as a family history of breast cancer, it could help identify women who might benefit from pre-emptive action.
Baroness Delyth Morgan, chief executive of Breast Cancer Campaign, said: "Dr Flanagan's research into epigenetics is so exciting because it suggests that there is every possibility the risk of developing breast cancer could be decided many decades in advance.
"By piecing together how this happens, we can look at ways of preventing the disease and detecting it earlier to give people the best possible chance of survival."
A bra which hope to detect breast cancer in wearers, before it can be seen in traditional scans, has shown promising early results. In a series of clinical trials, the bra successfully detected over 90% of breast tumours at a very early stage. Click here to read full story
According to new research, a genetic link has been made between breast size and breast cancer risks. Medical News Today reports that genetics company 23andMe has identified seven single-nucleotide polymorphisms (SNPs) - or genetic variations - significantly associated with breast size. Click here to read full story
Stress can hasten the spread of breast cancer to the bones, research suggests. Studies of mice showed that responses to stress made it easier for tumours to take root in the bone. Click here to read full story
Breast cancer screening leads to thousands of women undergoing unnecessary treatment despite saving lives, according to an independent review. Click here to read full story
Cancer Research Technology (CRT) has launched a spin-out company that will develop a next-generation of High Intensity Focused Ultrasound (HIFU) surgery to treat - and melt - cancer tumours. Click here to read the full story...
Almost half of women with the most common form of early breast cancer could be spared chemotherapy thanks to a genetic test, research suggests. The Oncotype DX test involves the examination of genes taken from a sample of a tumour removed during surgery. Click here to read the full story...
Breast cancer could be detected in seconds using new, anti-landmine technology. British scientists have developed a revolutionary breast-screening system that uses anti-landmine technology to detect cancer in seconds. The radio-wave scanner is safer, cheaper and less painful than traditional mammogram X-rays, and unlike the current system, can be used on women of all ages. Click here to read the full story...
According to new scientific research, eating a low glycemic index (GI) diet could drastically decrease the risks of breast cancer. Click here to read the full story...
The controversial link between hormone replacement therapy and breast cancer has resurfaced, with health experts claiming that there is no solid evidence that HRT increases breast cancer risks. Click here to read the full story...
New scientific evidence has indicated that common preservative chemicals found in underarm antiperspirants and thousands of other everyday products, can be detected in breast cancer tumours. Click here to read the full story...
Cancer drugs that are designed to shrink tumours by cutting off the supply to their blood may be doing the opposite and helping them spread to other parts of the body, a study has warned. Click here to read the full story...
A new treatment for breast cancer has been discovered after scientists found that breast tumours can be killed in minutes - by boiling them Click here to read the full story...
Women who have a strong family history of breast cancer should avoid drinking alcohol, a new study suggests. Health experts warn that women whose mothers, grandmothers and aunts have had breast cancer, are more than twice as likely to develop the disease than non-drinkers. Click here to read the full story...
The UK is lagging behind other countries on survival rates for breast, bowel and cervical cancer and has much higher hospital admission rates for asthma, research shows. Click here to read the full story...